Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

OBJECTIVE: The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly by observational studies and expert opinion. Further complicating trials in LVV is the absence of validated a...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Rheumatol
Main Authors: Aydin, Sibel Zehra, Direskeneli, Haner, Sreih, Antoine, Alibaz-Oner, Fatma, Gul, Ahmet, Kamali, Sevil, Hatemi, Gulen, Kermani, Tanaz, Mackie, Sarah L., Mahr, Alfred, Meara, Alexa, Milman, Nataliya, Nugent, Heidi, Robson, Joanna, Tomasson, Gunnar, Merkel, Peter A.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668221/
https://ncbi.nlm.nih.gov/pubmed/26077399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.141144
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍